Funding
← Back to your selection

LG Technology Ventures

Activity from announced rounds

Activity in this selectionUnited States · Oct 9, 2026 · Sep 10, 2026

LG Technology Ventures is the corporate venture organization identified in its own Spectro Cloud release and RegCell’s investor announcement.

Recorded funding activity

Spectro manages cloud infrastructure. RegCell reprograms immune cells for cell therapies, while Zenity secures enterprise agents. The venture organization retains its identity separately from the LG parent and other named units.

Sources
Rounds participated in
2
Confirmed lead rounds
0
All roles disclosed
New companies
2
First participation on record · 0 follow-on
Funding in participating rounds
$119M
2 disclosed · full round size, not this investor’s share

By stage

Series A1
Series C+1

By primary sector

Biotech2

By country

United States2

Rounds

2 in this selection
BigHat Biosciences

An AI and synthetic-biology platform that designs and engineers antibody therapeutics.

$75MSeries C
Participant
RegCell, Inc.

RegCell is developing cell therapies for autoimmune disease by epigenetically reprogramming pathogenic conventional T cells into stable regulatory T cells, aiming to restore immune tolerance without gene engineering; its platform is advancing toward clinical development.

$44MSeries A
Participant